Tilray Brands Inc. has cut its price target from $6 to $3 per share as it grapples with market share losses in the Canadian cannabis landscape and soft conditions in the U.S. alcohol market. Despite these headwinds, the company reports positive EBITDA margins and a notable year-over-year growth of 36.36%. In response to these challenges, Tilray is expanding its premium cannabis portfolio while pursuing the acquisition of Hexo Corp, aiming for $80 million in cost-saving synergies from the deal.